17 Jan 2012 Calon Cardio-Technology relocates to ILS2

Calon Cardio-Technology, the innovative LVAD pump company, today announces its relocation to the new state of the art Institute of Life Sciences (ILS2) facility.  Recently completed at a cost of £28.2m, the ILS2 is located on the Swansea University Singleton Park campus, strategically placed between the College of Medicine and Singleton Hospital. A bespoke 6000 square metre building, the ILS2 brings together all aspects of laboratory, clinical research, office and meeting space, and houses an Imaging Suite, the Centre for Health Information, Research and Evaluation (CHIRAL) and the Centre for NanoHealth. It also provides an extended range of fully operational business incubation units into which Calon have moved.

Kevin Fernquest, Managing Director of Calon complimented the ILS saying “the location and the quality of the facility are first class, providing access to the engineering, design, analytical, electronic and medical skills we require to be successful and additionally provides sufficient space for Calon to expand as and when we require it”.

For more information, contact Kevin Fernquest, Managing Director, Calon Cardio- Technologies, 01792 602861



Disclaimer: Calon Cardio’s VAD devices are not available for sale, including in the United States of America